⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AVXL News

Anavex Life Sciences

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial